Prehabilitation and Rehabilitation for Patients with Lung Cancer: A Review of Where we are Today-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prehabilitation and Rehabilitation for Patients with Lung Cancer: A Review of Where we are Today

Published:2022-11 Issue:11 Volume:34 Page:724-732
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Burnett C.,Bestall J.C.,Burke S.,Morgan E.,Murray R.L.,Greenwood-Wilson S.,Williams G.F.,Franks K.N.

Funder

National Institute for Health and Care Research

Yorkshire Cancer Research

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference79 articles.

1. Lung cancer statistics;Cancer Research Uk,2022

2. Cancer incidence and mortality projections in the UK until 2035;Smittenaar;Br J Cancer,2016

3. Comorbidity and survival in lung cancer patients;Islam;Cancer Epidemiol Biomarkers Prev,2015

4. Impact of comorbidity on lung cancer survival;Tammemagi;Int J Cancer,2003

5. The role of receipt and timeliness of treatment in socioeconomic inequalities in lung cancer survival: population-based, data-linkage study;Forrest;Thorax,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Summary of the best evidence for prehabilitation management of patients with non-small cell lung cancer;Asia-Pacific Journal of Oncology Nursing;2024-07

2. Identification of symptom clusters and sentinel symptoms during the first cycle of chemotherapy in patients with lung cancer;Supportive Care in Cancer;2024-05-27

3. Early prehabilitation reduces admissions and time in hospital in patients with newly diagnosed lung cancer;BMJ Supportive & Palliative Care;2024-04-17

4. Prehabilitation for Patients with Cancer Undergoing Radiation Therapy: a Scoping Review;Clinical Oncology;2024-04

5. Prognostic value of the Scottish Inflammatory prognostic Score in patients with NSCLC expressing PD-L1 ≥ 50 % progressing on first-line pembrolizumab;Lung Cancer;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3